To access this element change to forms mode OFF
Grant Award View - GA293062
PRECISION- PhaRmacogEnomiC medIcines optimiSatIon for peOple with caNcer
GA ID:
GA293062
Agency:
Department of Health and Aged Care
Approval Date:
6-Dec-2022
Publish Date:
30-Mar-2023
Category:
Medical Research
Grant Term:
29-Mar-2023 to 2-Sep-2027
Value (AUD):
$1,500,000.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 22/23 Health Policy Research and Analysis
Grant Program:
Medical Research Future Fund
Grant Activity:
PRECISION- PhaRmacogEnomiC medIcines optimiSatIon for peOple with caNcer
Purpose:
PRECISION is a multi-trial, multi-centre, mixed-methods program that will discover, translate, implement and evaluate an evidence-based approach to pharmacogenomic (PGx) medicines optimisation in adult and paediatric cancer cohorts. Conducting two clinical trials and using implementation science methods we will assess feasibility, acceptability, needs, cost effectiveness and scalability of PGx-guided medicines optimisation to enable safer and more effective use of medicines for people with cancer. Three program streams of clinical trials, implementation, and discovery, will simultaneously investigate multiple clinical and research questions whilst focused on confirming the feasibility of PGx in cancer care.
GO ID:
GO Title:
MRFF 2022 Quality, Safety and Effectiveness of Medicine Use and Medicine Intervention by Pharmacists
Internal Reference ID:
MRFMMIP000011
Selection Process:
Open Competitive
Confidentiality - Contract:
No
Confidentiality - Outputs:
No
Grant Recipient Details
Recipient Name:
UNIVERSITY OF MELBOURNE
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
MELBOURNE
Town/City:
MELBOURNE
Postcode:
3010
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
3000
Country:
AUSTRALIA